For example, the delivery of paclitaxel by anti-HER2/neu peptide-conjugated iron oxide nanoparticles to HER2/neu-overexpressing breast cancer cells has been demonstrated in a mouse model.11 Here, ERBB2 is linked to breast carcinoma.